While most tech startups chase vanity metrics, business.pregistry.com operates in a realm where a single data point can save a pregnancy. This isn't a consumer app—it's the silent backbone of pharmaceutical safety monitoring, where epidemiologists design the studies that determine which drugs are safe for expecting mothers.

"This isn't about scale—it's about precision. Nineteen people managing data that impacts millions of lives."

The absence of traffic metrics is telling. When your clients are Pfizer, Merck, and Novartis, you don't need organic search. You need clinical trial integrity, data privacy compliance, and the ability to run prospective cohort studies across multiple continents. The social profiles (Twitter, LinkedIn, YouTube) aren't for lead generation—they're for thought leadership in a field where reputation is everything.

• Niche dominance in pregnancy registry studies (a $500M+ market)
• Leverages parent company's $17.4B acquisition for credibility
• Ultra-specialized team (19 people) with high revenue per employee
• Modern tech stack despite pharma's reputation for legacy systems
• Zero public traffic = enterprise-only sales model